DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Chan AW, Moliterno DJ, Berger PB. , et al; TARGET Investigators.
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
J Am Coll Cardiol 2003;
42 (07) 1188-1195
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.